GliaCure

Link
gliacure.com
Название компании
GliaCure
Address
234 Causeway St, #809
City
Boston
Country
USA
Headquarters
Boston, MA 02114-2126
Stage of the project
Startup
Total Raised
$8,600,000
Description

GliaCure is a pioneer in the development of novel therapeutics aimed at treating neurological and neuropsychiatric disorders of the brain. The company’s approaches are based on glial targets, a cell type in the brain that has previously been overlooked in drug discovery.

The company has developed a small molecule clinical candidate — GC021109 — for a glial target that has two primary actions downstream of target engagement: the stimulation of phagocytosis and anti-inflammatory actions in which levels of pro-inflammatory cytokines are reduced.